These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 13676991)

  • 1. [Morpho-functional study of the glutamatergic, cholinergic, and dopaminergic systems interaction in the striatum].
    Oleshko NN
    Ross Fiziol Zh Im I M Sechenova; 1997; 83(1-2):96-101. PubMed ID: 13676991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphofunctional studies of the interactions of the glutamatergic, cholinergic, and dopaminergic systems in the neostriatum.
    Oleshko NN
    Neurosci Behav Physiol; 1998; 28(4):397-401. PubMed ID: 9762711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological interactions between striatal glutamatergic and dopaminergic systems.
    West AR; Floresco SB; Charara A; Rosenkranz JA; Grace AA
    Ann N Y Acad Sci; 2003 Nov; 1003():53-74. PubMed ID: 14684435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dopamine-acetylcholine cascade: simulating learned and lesion-induced behavior of striatal cholinergic interneurons.
    Tan CO; Bullock D
    J Neurophysiol; 2008 Oct; 100(4):2409-21. PubMed ID: 18715897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dopaminergic mechanisms of the neostriatum in the corticoliberin regulation of adaptive behavior].
    Shaliapina VG; Rybnikova EA; Rakitskaia VV; Turkina EV
    Ross Fiziol Zh Im I M Sechenova; 1998 Oct; 84(10):1146-51. PubMed ID: 10097283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum.
    Calabresi P; Pisani A; Centonze D; Bernardi G
    Neurosci Biobehav Rev; 1997 Jul; 21(4):519-23. PubMed ID: 9195611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,4-Methylenedioxymetamphetamine (ecstasy) induces c-fos-like protein and mRNA in rat organotypic dorsal striatal slices.
    Schatz DS; Kaufmann WA; Schuligoi R; Humpel C; Saria A
    Synapse; 2000 Apr; 36(1):75-83. PubMed ID: 10700028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat.
    Hernández LF; Segovia G; Mora F
    Neurochem Int; 2008 Feb; 52(3):457-69. PubMed ID: 17881090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Striatal mechanisms of corticoliberin effect on the behavior of dogs with dopamine deficiency].
    Voĭlokova NL; Suvorov NF; Rakitskaia VV; Shaliapina VG
    Ross Fiziol Zh Im I M Sechenova; 1998 Aug; 84(8):728-34. PubMed ID: 9845889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astroglial and microglial activation in the wistar rat ventral tegmental area after a single striatal injection of 6-hydroxydopamine.
    Rodrigues RW; Gomide VC; Chadi G
    Int J Neurosci; 2004 Feb; 114(2):197-216. PubMed ID: 14702208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease.
    Xue YQ; Zhao LR; Guo WP; Duan WM
    Neuroscience; 2007 May; 146(3):1245-58. PubMed ID: 17363174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.
    Lacombe E; Carcenac C; Boulet S; Feuerstein C; Bertrand A; Poupard A; Savasta M
    Eur J Neurosci; 2007 Sep; 26(6):1670-80. PubMed ID: 17822436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pallidal control of substantia nigra dopaminergic neuron firing pattern and its relation to extracellular neostriatal dopamine levels.
    Lee CR; Abercrombie ED; Tepper JM
    Neuroscience; 2004; 129(2):481-9. PubMed ID: 15501605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of synapsin I and II for neurotransmitter levels and vesicular storage in cholinergic, glutamatergic and GABAergic nerve terminals.
    Bogen IL; Haug KH; Roberg B; Fonnum F; Walaas SI
    Neurochem Int; 2009; 55(1-3):13-21. PubMed ID: 19428802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of systemic L-DOPA administration on extracellular kynurenate levels in the rat striatum.
    Wu HQ; Rassoulpour A; Schwarcz R
    J Neural Transm (Vienna); 2002 Mar; 109(3):239-49. PubMed ID: 11956948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of glutamate and dopamine in a computational model of the striatum.
    Kötter R; Wickens J
    J Comput Neurosci; 1995 Sep; 2(3):195-214. PubMed ID: 8521287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral lesions of mesostriatal dopaminergic pathway alters the withdrawal response of the rat hindpaw to mechanical stimulation.
    Takeda R; Ikeda T; Tsuda F; Abe H; Hashiguchi H; Ishida Y; Nishimori T
    Neurosci Res; 2005 May; 52(1):31-6. PubMed ID: 15811550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6-OHDA lesion.
    Meshul CK; Allen C
    Synapse; 2000 May; 36(2):129-42. PubMed ID: 10767060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic reorganisation in the rat striatum after dopaminergic deafferentation: an ultrastructural study using glutamate decarboxylase immunocytochemistry.
    Nitsch C; Riesenberg R
    Synapse; 1995 Apr; 19(4):247-63. PubMed ID: 7792720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical substrates and neuroanatomical generators of the event-related P300.
    Frodl-Bauch T; Bottlender R; Hegerl U
    Neuropsychobiology; 1999; 40(2):86-94. PubMed ID: 10474063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.